Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Figure 2

Median OS: 11.2 months (95% CI: 5.7–16.7). OS rate at 1 year: 39.6%. Median followup: 11.8 months.